Coeurative, Inc.
About Coeurative, Inc.
Coeurative, Inc. is a holding company founded in 2012 and based in Virginia, United States. It focuses on translational medicine and developing small molecule drugs targeting cardiovascular diseases, nervous system diseases, and other conditions. The company is developing innovative pharmaceutical strategies for coronary artery disease and angina pectoris, with a lead compound CR0305 that offers a dual mechanism of action for immediate relief and long-term vascular benefits. It has received NIH grant funding and maintains a small team of under 10 employees.
- 🔗 Coeurative, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
- 🔗 Coeurative, Inc, 201 McClanahan St SW, Roanoke, VA 24014-1709, US - MapQuest
- 🔗 Curative valued at $1.28B after funding round - Modern Healthcare
- 🔗 Cardiology Funding Roundup: Cardurion, Kestra, TRiCares all secure key investments
- 🔗 Fierce Healthcare Fundraising Tracker '26: Outro clinches $7M for deprescribing; Rightway pulls in $155M to expand pharmacy benefits tech
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Founded in 2012 as a Virginia-based holding company with under 10 employees.
- Focuses on small molecule drugs for cardiovascular and nervous system diseases.
- Lead compound CR0305 targets coronary artery disease and refractory angina.
- Received NIH grant funding alongside the $100,000 private placement.
- Located at 201 McClanahan St SW, Roanoke, VA.
Ask StreetZero about Coeurative, Inc.
Put our AI to work on this deal.
Similar companies
Other Other Health Care deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account